Vita Coco Company Inc (COCO) financial statements: income statement, balance sheet and cash flow
Vita Coco Company Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Vita Coco Company Inc reported revenue of $609.8M (+18.2% year on year) and net income of $71.3M (+27.5% year on year).
Income statement
Vita Coco Company Inc income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$609.8M
$516.0M
$493.6M
$427.8M
Cost of goods sold
$387.2M
$317.2M
$312.9M
$324.4M
Gross profit
$222.6M
$198.8M
$180.7M
$103.4M
Selling, general and administrative
$140.1M
$125.0M
$124.2M
$100.3M
Total operating expenses
$140.1M
$125.0M
$124.2M
$100.3M
Income from operations
$82.5M
$73.8M
$56.5M
$3.1M
Unrealized gain/(loss) on derivative instruments
$4.7M
($8.2M)
($872.0K)
$6.6M
Foreign currency loss
($1.0M)
($1.6M)
($251.0K)
$1.4M
Interest income, net
$6.5M
$6.7M
$2.6M
$51.0K
Other income
$191.0K
—
—
—
Total other income (expense)
$10.4M
($3.0M)
$1.4M
$7.8M
Income before income taxes
$93.0M
$70.8M
$57.9M
$10.8M
Income tax expense
$21.7M
$14.8M
($11.3M)
($3.0M)
Net income
$71.3M
$56.0M
$46.6M
$7.8M
Foreign currency translation adjustment
$1.3M
—
—
—
Basic (in dollars per share)
$1.25
$0.99
$0.83
$0.14
Diluted (in dollars per share)
$1.19
$0.94
$0.79
$0.14
Basic (in shares)
56.9M
56.7M
56.4M
55.7M
Diluted (in shares)
60.0M
59.3M
58.7M
56.1M
Vita Coco Company Inc income statement, quarters
Line item
Sep 30, 2026 · Q3
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Net sales
$243.8M
$216.2M
$179.8M
$182.3M
Cost of goods sold
$151.1M
$110.8M
$108.0M
$113.6M
Gross profit
$92.7M
$105.3M
$71.8M
$68.7M
Selling, general and administrative
$47.2M
$42.2M
$38.2M
$40.7M
Income from operations
$45.5M
$63.1M
$33.6M
$27.9M
Unrealized (loss) gain on derivative instruments
($2.1M)
($233.0K)
$2.8M
$2.4M
Foreign currency loss
($887.0K)
($1.0M)
($499.0K)
($1.4M)
Interest income, net
$1.2M
$2.5M
$1.6M
$1.8M
Other (expense) income, net
($84.0K)
$14.0K
($29.0K)
—
Total other (expense) income
($1.8M)
$1.2M
$3.9M
$2.8M
Income before income taxes
$43.6M
$64.4M
$37.4M
$30.7M
Income tax expense
$8.6M
$14.9M
$7.0M
$6.7M
Net income
$35.0M
$49.5M
$30.5M
$24.0M
Foreign currency translation adjustment
($763.0K)
($313.0K)
($460.0K)
($277.0K)
Total comprehensive income attributable to The Vita Coco Company, Inc.
$34.3M
$49.1M
$30.0M
$23.7M
Basic (in dollars per share)
$0.61
$0.86
$0.53
$0.42
Diluted (in dollars per share)
$0.58
$0.82
$0.50
$0.40
Basic (in shares)
57.5M
57.3M
57.1M
56.9M
Diluted (in shares)
60.8M
60.6M
60.5M
59.9M
Balance sheet
Vita Coco Company Inc balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$196.9M
$164.7M
$132.5M
$19.6M
Accounts receivable, net of allowance of $2,660 at December 31, 2025, and $2,255 at December 31, 2024
$81.5M
$63.5M
$50.1M
$43.4M
Inventory
$111.5M
$83.6M
$50.8M
$84.1M
Supplier advances, current
$693.0K
$954.0K
$1.5M
$1.5M
Derivative assets
$732.0K
$1.4M
$3.9M
$3.6M
Prepaid expenses and other current assets
$30.2M
$27.2M
$24.2M
$22.2M
Total current assets
$421.4M
$341.3M
$262.9M
$174.9M
Property and equipment, net
$9.3M
$2.4M
$2.1M
$2.1M
Goodwill
$7.8M
$7.8M
$7.8M
$7.8M
Supplier advances, long-term
$1.9M
$2.3M
$2.8M
$4.4M
Deferred tax assets, net
$6.5M
$6.1M
$6.7M
$4.3M
Right-of-use assets, net
$11.6M
$385.0K
$1.4M
$2.7M
Other assets
$2.7M
$2.2M
$1.8M
$1.7M
Total assets
$461.2M
$362.4M
$285.7M
$197.8M
Accounts payable
$25.5M
$30.8M
$21.8M
$15.9M
Accrued expenses and other current liabilities
$89.5M
$65.6M
$59.5M
$38.3M
Notes payable, current
$3.0K
$10.0K
$13.0K
$23.0K
Derivative liabilities
$1.5M
$6.9M
$1.2M
$71.0K
Total current liabilities
$116.4M
$103.3M
$82.6M
$54.3M
Notes payable, long-term
$0
$3.0K
$13.0K
$25.0K
Non-current portion of operating lease liabilities
$13.1M
—
—
—
Other long-term liabilities
$97.0K
$295.0K
$647.0K
$2.3M
Total liabilities
$129.6M
$103.6M
$83.2M
$56.7M
Common stock, $0.01 par value; 500,000,000 shares authorized; 64,186,549 and 63,702,387 shares issued at December 31, 2025 and December 31, 2024, respectively; 57,082,173 and 56,961,941 shares outstanding at December 31, 2025 and December 31, 2024, respectively.
642.0K
637.0K
631.0K
622.0K
Additional paid-in capital
$185.4M
$174.1M
$161.4M
$145.2M
Retained earnings
$228.0M
$156.7M
$100.7M
$55.2M
Accumulated other comprehensive gain (loss)
$486.0K
($860.0K)
($649.0K)
($994.0K)
Treasury stock, 7,104,376 shares at cost as of December 31, 2025, and 6,740,446 as of December 31, 2024.
-83.0M
-71.7M
-59.7M
-58.9M
Total stockholders’ equity
$331.5M
$258.8M
$202.4M
$141.1M
Total liabilities and stockholders’ equity
$461.2M
$362.4M
$285.7M
$197.8M
Vita Coco Company Inc balance sheet, quarters
Line item
Sep 30, 2026
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Cash and cash equivalents
$152.0M
$278.6M
$201.9M
$203.7M
Accounts receivable, net of allowance of $3,282 at September 30, 2026, and $2,660 at December 31, 2025
$128.7M
$132.3M
$120.8M
$103.4M
Inventory
$111.3M
$82.9M
$86.4M
$84.4M
Supplier advances, current
$339.0K
$452.0K
$626.0K
$767.0K
Derivative assets
$1.8M
$2.9M
$3.0M
$2.2M
Prepaid expenses and other current assets
$39.5M
$37.8M
$36.9M
$28.9M
Total current assets
$433.7M
$535.0M
$449.7M
$423.3M
Property and equipment, net
$24.4M
$8.9M
$9.3M
$7.2M
Goodwill
$110.2M
$7.8M
$7.8M
$7.8M
Intangible assets, net
$107.1M
—
—
—
Supplier advances, long-term
$1.6M
$1.7M
$1.8M
$2.4M
Deferred tax assets
$6.6M
$6.5M
$6.5M
$6.1M
Right-of-use assets, net
$10.3M
$10.6M
$10.9M
$11.9M
Other assets
$2.2M
$2.4M
$2.4M
$2.6M
Total assets
$696.1M
$572.9M
$488.3M
$461.3M
Accounts payable
$46.4M
$31.0M
$24.8M
$22.3M
Accrued expenses and other current liabilities
$126.6M
$127.3M
$97.4M
$99.8M
Derivative liabilities
$2.1M
$1.1M
$912.0K
$1.4M
Total current liabilities
$175.1M
$159.4M
$123.2M
$123.5M
Deferred tax liability
$24.9M
—
—
—
Operating lease liability, long-term
$12.1M
$12.5M
$12.9M
$14.0M
Seller's earn-out
$55.1M
—
—
—
Other long-term liabilities
$240.0K
$92.0K
$99.0K
$98.0K
Total liabilities
$267.4M
$172.0M
$136.2M
$137.6M
Common stock, $0.01 par value; 500,000,000 shares authorized; 65,396,253 and 64,186,549 shares issued at September 30, 2026 and December 31, 2025, respectively; 57,202,356 and 57,082,173 shares outstanding at September 30, 2026 and December 31, 2025, respectively
654.0K
649.0K
644.0K
640.0K
Additional paid-in capital
$231.6M
$195.6M
$187.5M
$182.0M
Retained earnings
$343.0M
$307.9M
$258.5M
$222.5M
Accumulated other comprehensive gain (loss)
($1.1M)
($287.0K)
$26.0K
$549.0K
Treasury stock, 8,193,897 shares at cost as of September 30, 2026, and 7,104,376 shares at cost as of December 31, 2025.
-145.4M
-103.0M
-94.5M
-81.9M
Total stockholders’ equity
$428.7M
$400.9M
$352.2M
$323.7M
Total liabilities and stockholders’ equity
$696.1M
$572.9M
$488.3M
$461.3M
Cash flow statement
Vita Coco Company Inc cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income
$71.3M
$56.0M
$46.6M
$7.8M
Depreciation and amortization
$1.1M
$745.0K
$660.0K
$1.9M
Amortization of debt issuance costs
$16.0K
—
—
—
Loss on disposal of equipment
$1.0K
$13.0K
$19.0K
$1.0K
Provision for credit losses
$2.0M
$1.6M
$260.0K
$2.6M
Unrealized (gain)/loss on derivative instruments
($4.7M)
$8.2M
$872.0K
($6.6M)
Stock-based compensation
$10.8M
$8.9M
$9.1M
$7.4M
Impairment loss on assets held for sale
$0
$0
$363.0K
$619.0K
Impairment loss on Runa assets
$185.0K
$0
$0
$6.7M
Noncash lease expense
$1.4M
$1.0M
$1.3M
$1.1M
Deferred tax expense
($366.0K)
$644.0K
($2.4M)
($3.1M)
Accounts receivable
($18.6M)
($14.2M)
($7.1M)
$321.0K
Inventory
($27.3M)
($33.0M)
$33.7M
($9.3M)
Prepaid expenses, net supplier advances, and other assets
$130.0K
($2.7M)
($622.0K)
($3.6M)
Accounts payable, accrued expenses, and other liabilities
$11.2M
$15.7M
$24.3M
($16.8M)
Net cash provided by operating activities
$47.2M
$42.9M
$107.2M
($10.9M)
Cash paid for property and equipment
($8.1M)
($974.0K)
($599.0K)
($982.0K)
Proceeds from sale of property and equipment
$0
$0
$5.0K
$0
Equity method investment in joint venture
($104.0K)
—
—
—
Net cash used in investing activities
($8.3M)
($974.0K)
($594.0K)
($982.0K)
Proceeds from exercise of stock awards
$3.7M
$3.7M
$7.1M
$3.1M
Cash paid on notes payable
($10.0K)
($13.0K)
($23.0K)
($28.0K)
Cash paid to acquire treasury stock
($11.3M)
($12.0M)
($773.0K)
$0
Net cash provided by (used in) financing activities
($7.5M)
($8.3M)
$6.3M
$3.0M
Effects of exchange rate changes on cash and cash equivalents
$834.0K
($563.0K)
$387.0K
($178.0K)
Net increase in cash and cash equivalents
$32.2M
$33.1M
$113.2M
($9.1M)
Cash, cash equivalents and restricted cash at beginning of the period
$165.9M
$132.9M
$19.6M
$28.7M
Cash, cash equivalents and restricted cash at end of the period
$198.2M
$165.9M
—
—
Cash paid for interest
$0
$1.0K
$75.0K
$217.0K
Restricted cash
$1.3M
$1.3M
$330.0K
—
Vita Coco Company Inc cash flow statement, quarters
Line item
Sep 30, 2026 · YTD
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Net income attributable to The Vita Coco Company, Inc.
$114.9M
$79.9M
$30.5M
$65.8M
Depreciation and amortization
$2.5M
$965.0K
$476.0K
$636.0K
Amortization of debt issuance cost
$14.0K
$9.0K
$5.0K
$11.0K
Increase of provision for credit losses
$187.0K
($829.0K)
($384.0K)
$1.3M
Unrealized (gain) on derivative instruments
($511.0K)
($2.6M)
($2.8M)
($6.3M)
Stock-based compensation
$11.3M
$8.2M
$4.6M
$8.1M
Impairment loss on Runa assets
$0
—
—
$185.0K
Noncash lease expense
$1.2M
$935.0K
$633.0K
$1.1M
Accounts receivable
($42.8M)
($50.6M)
($39.4M)
($39.7M)
Inventory
$33.3M
$28.3M
$24.8M
($302.0K)
Prepaid expenses, net supplier advances, and other assets
($7.2M)
($7.2M)
($6.5M)
$345.0K
Accounts payable, accrued expenses, and other liabilities
$39.0M
$39.4M
$3.8M
$19.9M
Net cash provided by operating activities
$151.9M
$96.5M
$15.6M
$51.1M
Cash paid for property and equipment
($803.0K)
($612.0K)
($461.0K)
($4.9M)
Acquisition of Copra Inc., net of $8,340 cash acquired
($139.3M)
—
—
—
Net cash used in investing activities
($140.1M)
($612.0K)
($461.0K)
($4.9M)
Proceeds from exercise of stock awards
$6.1M
$6.1M
$1.6M
$2.3M
Cash paid on notes payable
($3.0K)
($3.0K)
($3.0K)
($8.0K)
Cash paid to acquire treasury stock
($62.4M)
($20.0M)
($11.5M)
($10.2M)
Net cash used in financing activities
($56.3M)
($13.9M)
($9.9M)
($7.9M)
Effects of exchange rate changes on cash and cash equivalents
($475.0K)
($246.0K)
($195.0K)
$833.0K
Net (decrease) increase in cash and cash equivalents
($44.9M)
$81.8M
$5.0M
$39.0M
Cash, cash equivalents and restricted cash at beginning of the period
$198.2M
$198.2M
$198.2M
$165.9M
Cash, cash equivalents and restricted cash at end of period